Explore/

Biggest Earnings Beats

Biggest Earnings Beats

7.07k followers3 symbols Watchlist by Yahoo Finance

This list tracks the largest earnings beats for companies recently reporting earnings. This list is produced daily using the real-time earnings results reported by Selerity and limited to the top 30 stocks that meet the criteria.

3 Symbols

  • Thomson Reuters StreetEvents

    Edited Transcript of MKC earnings conference call or presentation 31-Mar-20 12:00pm GMT

    Q1 2020 McCormick & Company Inc Earnings Call

  • Company News for Apr 3, 2020
    Zacks

    Company News for Apr 3, 2020

    Companies In The News Are: NEPT, BMRA, LK, WBA

  • CarMax, Inc. (NYSE:KMX) Analysts Just Cut Their EPS Forecasts Substantially
    Simply Wall St.

    CarMax, Inc. (NYSE:KMX) Analysts Just Cut Their EPS Forecasts Substantially

    The analysts covering CarMax, Inc. (NYSE:KMX) delivered a dose of negativity to shareholders today, by making a...

  • Thomson Reuters StreetEvents

    Edited Transcript of WBA earnings conference call or presentation 2-Apr-20 12:30pm GMT

    Q2 2020 Walgreens Boots Alliance Inc Earnings Call

  • Thomson Reuters StreetEvents

    Edited Transcript of KMX earnings conference call or presentation 2-Apr-20 1:00pm GMT

    Q4 2020 Carmax Inc Earnings Call

  • Walgreens Slumps After Executives Flag Downturn in Sales
    Bloomberg

    Walgreens Slumps After Executives Flag Downturn in Sales

    (Bloomberg) -- Walgreens Boots Alliance Inc. sank after executives said sales have started to decline at its drugstores as a result of the coronavirus pandemic, though the full impact on its business won’t be known for months.U.S. consumers had raced early last month to stock up on drugs, cleaning supplies and toilet paper as they prepared to stay at home to avoid getting or spreading Covid-19. Now, that rush appears to be ebbing.In the first three weeks of March, Walgreens’ comparable sales rose about 26%, Chief Financial Officer James Kehoe said on a call Thursday with Wall Street analysts, adding that health and grocery sales surged while discretionary categories like beauty slumped. However, sales began to fall in the last 10 days of March, declining at a mid-teens percentage rate.“Obviously, if this trend continues for an extended period, it will quickly offset the sales uplift seen in the first 21 days of March,” Kehoe said.Kehoe said the pharmacy business experienced similar trends, though less pronounced, with patients refilling prescriptions early.Shares fell 7% to $40.01 at 10:27 a.m. in New York. Since the beginning of 2020, the stock had declined 27% through the close of trading Wednesday.Earlier Thursday, Walgreens posted better-than-expected results for its second quarter but cautioned that the Covid-19 pandemic makes the future uncertain. The Deerfield, Illinois-based company said it would update its financial guidance in its next quarterly report. Previously, it had projected roughly flat growth in adjusted earnings per share.Chief Executive Officer Stefano Pessina said while the company’s second-quarter results were better than expectations, “it is too early to know what the net impact of the Covid-19 pandemic will be on our performance for the year.”Early SignsThe comments from Walgreens offer an early look at how businesses have been faring since the start of the coronavirus pandemic. While the company’s quarter ended on Feb. 29, before the worst of the Covid-19 outbreak in the U.S. and the most ambitious of the social-distancing efforts to contain it, executives indicated on the call with analysts that recent weeks have become more challenging.Walgreens executives stressed they think the situation is temporary, but Pessina said if the pandemic lasts more than a month its effects will be longer-lasting.“The world will be different later on,” he said. “Many things will have changed, their habits will be different.”Walgreens had already been trying to bolster its digital strategy before the outbreak. It has since made delivery free on its website and expanded a partnership with delivery service Postmates, among other efforts.In its second-quarter report, Walgreens said comparable sales at its U.S. stores rose 2.7% from a year earlier. At the pharmacy counter, sales rose 5.3%, which the company attributed to more expensive prescription drugs, more prescriptions filled and growth in its specialty business.Walgreens removed e-cigarettes from its U.S. stores last fall and has said it will de-emphasize tobacco. Those decisions weighed on results, as comparable retail sales rose 0.6% in the quarter, or 1.9% when excluding these products.Second-quarter adjusted earnings per share of $1.52, down from $1.64 a year earlier but better than the $1.46 Wall Street analysts expected, on average.(Adds more comments from Walgreens executives beginning in 10th paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down
    Zacks

    Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down

    The coronavirus outbreak had an immaterial impact on Walgreens Boots' (WBA) second-quarter fiscal 2020 results.

  • CarMax's (KMX) Q4 Earnings & Sales Surpass Estimates, Up Y/Y
    Zacks

    CarMax's (KMX) Q4 Earnings & Sales Surpass Estimates, Up Y/Y

    CarMax (KMX) posts better-than-expected earnings in the fiscal fourth quarter as well as registers stellar revenues across all segments.

  • Walgreens Boots Stock Falls 8%
    Investing.com

    Walgreens Boots Stock Falls 8%

    Investing.com - Walgreens Boots (NASDAQ:WBA) Stock fell by 7.59% to trade at $39.71 by 12:40 (16:40 GMT) on Thursday on the NASDAQ exchange.

  • Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Beat Estimates
    Zacks

    Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Beat Estimates

    Walgreens (WBA) delivered earnings and revenue surprises of 4.83% and 1.48%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?

  • CarMax (KMX) Q4 Earnings and Revenues Top Estimates
    Zacks

    CarMax (KMX) Q4 Earnings and Revenues Top Estimates

    CarMax (KMX) delivered earnings and revenue surprises of 16.07% and 6.37%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Walgreens Boots Earnings, Revenue Beat in Q2
    Investing.com

    Walgreens Boots Earnings, Revenue Beat in Q2

    Investing.com - Walgreens Boots (NASDAQ:WBA) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

  • Moody's: Clinical trials troubled amid coronavirus outbreak, drug sales not so much
    Yahoo Finance

    Moody's: Clinical trials troubled amid coronavirus outbreak, drug sales not so much

    Anecdotal reports of clinical drug trials being disrupted by the coronavirus outbreak have caused concern for the life sciences sector at large, though it appears vaccine trials for COVID-19 won’t be affected, according to Moody’s.

  • Why Walgreens Boots Alliance (WBA) Might Surprise This Earnings Season
    Zacks

    Why Walgreens Boots Alliance (WBA) Might Surprise This Earnings Season

    Walgreens Boots Alliance (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • Why Earnings Season Could Be Great for CarMax (KMX)
    Zacks

    Why Earnings Season Could Be Great for CarMax (KMX)

    CarMax (KMX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • Walgreens Boots Stock Falls 4%
    Investing.com

    Walgreens Boots Stock Falls 4%

    Investing.com - Walgreens Boots (NASDAQ:WBA) Stock fell by 4.05% to trade at $43.87 by 12:39 (16:39 GMT) on Wednesday on the NASDAQ exchange.

  • Can Retail Pharmacy USA Aid Walgreen Boots' (WBA) Q2 Earnings?
    Zacks

    Can Retail Pharmacy USA Aid Walgreen Boots' (WBA) Q2 Earnings?

    Solid prescription volume growth and brand inflation anticipated to have aided Walgreen Boots' (WBA) Retail Pharmacy USA performance in Q2.

  • McCormick (MKC) Q1 Earnings Beat Estimates, Outlook Withdrawn
    Zacks

    McCormick (MKC) Q1 Earnings Beat Estimates, Outlook Withdrawn

    McCormick's (MKC) fiscal first-quarter 2020 results reflect soft earnings. Also, the COVID-19 outbreak in China reduced the company's sales growth in the quarter.

  • McCormick (MKC) Tops Q1 Earnings Estimates
    Zacks

    McCormick (MKC) Tops Q1 Earnings Estimates

    McCormick (MKC) delivered earnings and revenue surprises of 4.85% and -1.37%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Walgreens Boots Stock Rises 4%
    Investing.com

    Walgreens Boots Stock Rises 4%

    Investing.com - Walgreens Boots (NASDAQ:WBA) Stock rose by 4.03% to trade at $46.98 by 10:12 (14:12 GMT) on Tuesday on the NASDAQ exchange.

  • Will Used-Vehicle Sales Buoy CarMax's (KMX) Q4 Earnings?
    Zacks

    Will Used-Vehicle Sales Buoy CarMax's (KMX) Q4 Earnings?

    While CarMax (KMX) is likely to have witnessed high SG&A costs, increasing revenues from the used-vehicle segment are anticipated to aid results for the to-be-reported quarter.

  • Auto Stock Roundup: Coronavirus-Related Updates Spell Shakeout for the Sector
    Zacks

    Auto Stock Roundup: Coronavirus-Related Updates Spell Shakeout for the Sector

    Check out the actions taken by various carmakers in the wake of coronavirus crisis.

  • JPMorgan, Wells Fargo, Walgreens, Constellation Brands and Nike are part of Zacks Earnings Preview
    Zacks

    JPMorgan, Wells Fargo, Walgreens, Constellation Brands and Nike are part of Zacks Earnings Preview

    JPMorgan, Wells Fargo, Walgreens, Constellation Brands and Nike are part of Zacks Earnings Preview

  • Factors Influencing Constellation Brands' (STZ) Q4 Earnings
    Zacks

    Factors Influencing Constellation Brands' (STZ) Q4 Earnings

    Constellation Brands' (STZ) fourth-quarter fiscal 2020 results are likely to reflect gains from the robust corona beer business, innovation pipeline and strong depletion growth.